[An improvement in insulin efficacy in patients with type-1 diabetes mellitus following treatment using an insulin infusion pump].
In 8 patients with diabetes mellitus type I two methods for intensified insulin treatment were compared: method of numerous insulin applications and treatment with a subcutaneous insulin pump (Microjet model of "Miles" company). The following were taken into consideration: daily insulin dose, residuary beta-cell secretion (determined by a venous Tolbutamide test and dynamic follow up of C-peptide), peripherial insulin efficiency (M) determined in vivo by an euglycemic hyperinsulinemic clamp-technique (Biostator). The infusion pump treatment imitates the beta-cell function better than the numerous insulin applications. This method of treatment helps in overcoming the insulin deficiency and the jatrogenic hyperinsulinemia and as a result the metabolic compensation and insulin efficiency are improved.
Borisova
A M
AM
Koev
D
D
Kirilov
G
G
D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D002908:Chronic Disease; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D014044:Tolbutamide
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D014044:Tolbutamide
Podobriavane na insulinovata efektivnost pri bolni sŭs zakharna bolest tip I sled lechenie s insulinova infuzionna pompa.